Sophie Cheng
About Sophie Cheng
Sophie Cheng is a Clinical Trial Manager at Bristol Myers Squibb, overseeing clinical trials in China Mainland and Hong Kong. She previously worked at AstraZeneca and Jiading Yingyuan Hospital and holds a Bachelor's degree in Chinese Medicine from Shanghai University of Traditional Chinese Medicine.
Current Role at Bristol Myers Squibb
Sophie Cheng currently holds the position of Clinical Trial Manager (PM) at Bristol Myers Squibb. Since May 2014, she has been responsible for overseeing clinical trial operations from start-up to closure. Her role includes ensuring adherence to timelines, budgets, and quality standards for clinical trials conducted in China Mainland and Hong Kong. Additionally, she serves as the primary point of contact for both internal and external stakeholders at the country level.
Previous Experience at AstraZeneca
Before joining Bristol Myers Squibb, Sophie Cheng worked at AstraZeneca as a Clinical Research Associate (CRA) from 2010 to 2014. During her four-year tenure, she was involved in various aspects of clinical research, contributing to the effective management and progress of multiple clinical trials.
Work at Jiading Yingyuan Hospital
Sophie Cheng started her professional career as a Traditional Chinese Physician at Jiading Yingyuan Hospital, where she worked from 2009 to 2010. During her one year of service, she applied her knowledge of traditional Chinese medicine to treat patients, laying the foundation for her subsequent roles in clinical research and trial management.
Educational Background
Sophie Cheng studied at the Shanghai University of Traditional Chinese Medicine, where she completed her Bachelor's degree in Chinese Medicine from 2004 to 2009. Her education provided her with a solid understanding of traditional Chinese medical practices, which she later integrated into her career in clinical research and trial management.
Clinical Trial Management Responsibilities
In her role as Clinical Trial Manager, Sophie Cheng is tasked with managing clinical trials specifically in China Mainland and Hong Kong. Her responsibilities include ensuring that trials adhere to established timelines, budgets, and quality standards. She oversees the entire trial process from start-up to closure and serves as the main point of contact for both internal and external stakeholders involved in the trials.